Vetted by NeuralPress's Multi-Agent Verifier for strict factual validity and event relevance. Our compliance engine cross-checks and filters search results to ensure zero false correlations or misleading content, in full compliance with the Online Safety Act of Sri Lanka.
Hemas Holdings FY2026 Revenue by Segment
Comparison of revenue performance across key business units for FY2026.
Primary Sources
Hemas Holdings Marks a Milestone Year: FY26 Delivers the Strongest ...
Hemas Holdings PLC today announced record earnings for both the fourth quarter (Q4) and full financial year FY26, marking a historic milestone for the Group. Group earnings reached Rs. 3.03 Bn in Q4, representing 17.6% year-on-year (YoY) growth, and Rs. 8.92 Bn for the full year, up 10.7% YoY.Consumer BrandsHealthcareMobilityStrategy and Outlook Revenue for FY26 grew 8.0% to Rs. 127.4 Bn, and all three key business units recorded revenue growth, both annually and quarterly. Gross profit margin expanded by 110 basis points, reflecting stronger commercial execution. Hemas elected to reinvest that gain, and incrementally more, into the operating platform required to sustain the next phase of growth, including manpower capabilities, digital infrastructure, and an expanding healthcare network. As a result, EBITDA and EBIT margins compressed by 40 and 50 basis points respectively, which is the expected consequence of running operating expenditure ahead of revenue during an accelerating investment cycle. However, finance cost management more than offset this margin compression at the net profit level, as net profit margin and earnings per share expanded, returning year-on-year earnings margin growth to shareholders. The modest compression in ROE reflects the accumulation of retained earnings, as the Group continues to self-fund its investment pipeline through internally generated cash flows. This deliberate approach reflects both the quality of earnings and the resilience of the balance sheet. Quarterly PerformanceAnnual Performance Q4 FY26YoYFY26YoYRevenueRs. 31,540 Mn3.9%Rs. 127,362 Mn8.0%Consumer BrandsRs. 10,545 Mn4.5%Rs. 47,027 Mn2.2%HealthcareRs. 20,409 Mn3.4%Rs. 78,009 Mn11.5%MobilityRs. 563 Mn15.6%Rs. 2,293 Mn17.8%GPRs. 10,889 Mn16.9%Rs. 41,428 Mn11.7%GP margin34.5%3.8%32.5%1.1%EBITDARs 4,915 Mn11.8%Rs 16,449 Mn4.7%EBITDA margin15.6%1.1%12.9%(0.4%)EBITRs 4,337 Mn13.5%Rs. 14,145 Mn3.2%EBIT margin13.8%1.2%11.1%(0.5%)Net finance costRs. 172 Mn(25.9%)Rs. 421 Mn(56.9%)EarningsRs. 3,030 Mn17.6%Rs. 8,921 Mn10.7%Earnings margin9.6%1.1%7.0%0.2% Consumer Brands Consumer Brands revenue grew 2.2% YoY while earnings grew stronger at 6.5% YoY in FY26, underpinned by volume growth across all business units signalling recovering consumer demand. Home and Personal Care-Sri Lanka recorded volume growth of 4.2% in FY26, alongside a price degrowth of 1.3%. Personal Wash and Personal Care volumes expanded by 6.8% and 7.7%, respectively. Beauty, a strategic focus, record...
Hemas Holdings marks milestone year in 2025/26 | Daily FT
Group CEO Ashish Chandra Achieves strongest Group earnings Says over $ 100 m earmarked for investments in next four years With planned FY27 acquisitions, international revenue to increase to 10% from 3% Hemas Holdings PLC has announced record earnings for both the fourth quarter and full financial year 2025/26, marking a historic milestone for the Group. Group earnings reached Rs. 3.03 billion in 4Q, representing 17.6% year-on-year (YoY) growth, and Rs. 8.92 billon for the full year, up 10.7% YoY. Revenue for FY26 grew 8% to Rs. 127.4 billion, and all three key business units recorded revenue growth, both annually and quarterly. Gross profit margin expanded by 110 basis points (bps), reflecting stronger commercial execution. Hemas elected to reinvest that gain, and incrementally more, into the operating platform required to sustain the next phase of growth, including manpower capabilities, digital infrastructure, and an expanding healthcare network. As a result, Earnings Before Interest, Taxes, Depreciation and Amortisation (EBITDA) and Earnings Before Interest and Taxes (EBIT) margins compressed by 40 and 50 bps respectively, which is the expected consequence of running operating expenditure ahead of revenue during an accelerating investment cycle. However, finance cost management more than offset this margin compression at the net profit level, as net profit margin and earnings per share expanded, returning YoY earnings margin growth to shareholders. The modest compression in Return on Equity (ROE) reflects the accumulation of retained earnings, as the Group continues to self-fund its investment pipeline through internally generated cash flows. This deliberate approach reflects both the quality of earnings and the resilience of the balance sheet. Group CEO Ashish Chandra said digitalisation continues to advance at pace, locally, globally, and across the Group, creating new efficiencies and sharper insights. As part of the Group’s digital transformation agenda, significant investments are being directed towards modernising technology infrastructure, including ERP systems, HR information systems, hospital management platforms, salesforce automation, cyber security, and a data lake with Agentic and Generative Artificial Intelligence (AI)-based solutions. Alongside this, the Group continues to build the skills and capabilities its workforce will need to succeed in an increasingly digital and AI-driven environment. “On the business front, each Hemas entity ...
Hem Holdings Board Meeting for FY26 Results — Tulsian AI
Hem Holdings board meeting scheduled for May 27, 2026 to approve audited financial results for Q4 and FY ended March 31, 2026. Trading window for insiders close
Annual Report FY2024/25 (Hemas Holdings plc) - WorldNews
) HEMAS HOLDINGS PLC | ANNUAL REPORT 2024/25 C R A F T N G PROSPERITY C R A F T N G PROSPERITY At Hemas, prosperity has never been left to chance. We have always pursued it with purpose, resilience, and vision - and now, the time to surge ahead is here. Standing at the threshold of a transformative new chapter, we are more prepared than ever to realise our full potential. Over the past year ...
